Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice

Neurobiology of Disease

Volumn 23, Issue 3, 2006, Pages 563-572

  Oksman, M ^a   Iivonen, H ^a   Hogyes, E ^b   Amtul, Z ^b   Penke, B ^c   Leenders, I ^d   Broersen, L ^d   Lutjohann D ^e   Hartmann, T ^b   Tanila, H ^a,f  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF SZEGED   (Hungary)

^d NUMICO RESEARCH   (Netherlands)

^e UNIVERSITY OF BONN   (Germany)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Amyloid plaque; DHA; Lipid; n 3; Omega 3; PUFA

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; CHOLESTEROL; DOCOSAHEXAENOIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SOYBEAN OIL;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT INTAKE; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; LEARNING; MAZE TEST; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CHOLESTEROL; DIETARY FATS, UNSATURATED; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; ENCEPHALITIS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FOOD, FORMULATED; GLIOSIS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MICROGLIA; PRESENILIN-1; SENILE PLAQUES; TREATMENT OUTCOME;

EID: 33747180133     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.04.013     Document Type: Article

References (39)

1. Barberger-Gateau P., Letenneur L., Deschamps V., Peres K., Dartigues J.F., and Renaud S. Fish, meat, and risk of dementia: cohort study. BMJ 325 (2002) 932-933
2. Bourre J.M. Dietary omega-3 fatty acids and psychiatry: mood, behavior, stress, depression, dementia and aging. J. Nutr. Health Aging 9 (2005) 31-38
3. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., Rostaing P., Triller A., Salem Jr. N., Ashe K.H., Frautschy S.A., and Cole G.M. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43 (2004) 633-645
4. Duering M., Grimm O., Grimm H.S., Schröder J., and Hartmann T. Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42. Neurobiol. Aging 26 (2005) 785-788
5. Dyerberg J., Leaf A., and Galli C. ISSFAL Board Statement: recommendations for the essential fatty acid requirement for infant formulas. International society for the study of fatty acids and lipids. J. Am. Coll. Nutr. 14 (1995) 213-214
6. Engelhart M.J., Geerlings M.I., Ruitenberg A., Van Swieten J.C., Hofman A., Witteman J.C., and Breteler M.M. Diet and risk of dementia: does fat matter? The Rotterdam Study. Neurology 59 (2002) 1915-1921
7. Folch J. J. Biol.Chem. 226 (1957) 497-509
8. George A.J., Holsinger R.M., McLean C.A., Laughton K.M., Beyreuther K., Evin G., Masters C.L., and Li Q.X. APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease. Neurobiol. Dis. 16 (2004) 124-132
9. Green P., Glozman S., Kamensky B., and Yavin E. Developmental changes in rat brain membrane lipids and fatty acids. The preferential prenatal accumulation of docosahexaenoic acid. J. Lipid Res. 40 (1999) 960-966
10. Grimm H.S., Beher D., Lichtenthaler S.F., Shearman M.S., Beyreuther K., and Hartmann T. Gamma-Secretase cleavage site specificity differs for intracellular and secretory amyloid beta. J. Biol. Chem. 278 (2003) 13077-13085
11. Hannah V.C., Ou J., Luong A., Goldstein J.L., and Brown M.S. Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J. Biol. Chem. 276 (2000) 4365-4372
12. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H., and Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J. Nutr. 135 (2005) 549-555
13. Horrocks L.A., and Yeo Y.K. Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40 (1999) 211-225
14. Howland D.S., Trusko S.P., Savage M.J., Reaume A.G., Lang D.M., Hirsch J.D., Maeda N., Siman R., Greenberg B.D., Scott R.W., and Flood D.G. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J. Biol. Chem. 273 (1998) 16576-16582
15. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., Copeland N.G., Lee M.K., Younkin L.H., Wagner S.L., Younkin S.G., and Borchelt D.R. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13 (2004) 159-170
16. Jensen M., Hartmann T., Engvall B., Wang R., Uljon S.N., Sennvik K., Näslund J., Muehlhauser F., Nordstedt C., Beyreuther K., and Lannfelt L. Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems, 2000. Mol. Med. 6 (2000) 291-302
17. Jensen M.T., Cracchiolo J.R., and Arendash G.W. Long-Term Effects of Dietary Omega-3 and Omega-6 Fatty Acid Manipulation in Alzheimer's Transgenic Mice (2004), Society for Neuroscience, Washington, DC Program No. 830, 13
18. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., and Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 42 (1997) 776-782
19. Kitajka K., Puskas L.G., Zvara A., Hackler Jr. L., Barcelo-Coblijn G., Yeo Y.K., and Farkas T. The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc. Natl. Acad. Sci. 99 (2002) 2619-2624
20. Kivipelto M., Helkala E.L., Laakso M.P., Hänninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., and Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322 (2001) 1447-1451
21. Levin-Allerhand J.A., Lominska C.E., and Smith J.D. Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. J. Nutr. Health Aging 6 (2002) 315-319
22. Lim G.P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., Salem Jr. N., Frautschy S.A., and Cole G.M. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J. Neurosci. 25 (2005) 3032-3040
23. Litman B.J., and Mitchell D.C. A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids 31 (1996) S193-S197
24. Liu L., Ikonen S., Heikkinen T., Tapiola T., van Groen T., and Tanila H. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice. Exp. Neurol. 173 (2002) 196-204
25. Lütjohann D., Stroick M., Bertsch T., Kuhl S., Lindenthal B., Thelen K., Andersson U., Björkhem I., Bergmann K., and Fassbender K. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids 69 (2004) 431-438
26. Minkeviciene R., Banerjee P., and Tanila H. Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. JPET 311 (2004) 677-682
27. Moriguchi T., Greiner R.S., and Salem Jr. N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J. Neurochem. 75 (2000) 2563-2573
28. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N., Schneider J., and Wilson R.S. Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol. 60 (2003) 194-200
29. Raederstorff D., Pantze M., Bachmann H., and Moser U. Anti-inflammatory properties of docosahexaenoic and eicosapentaenoic acids in phorbol-ester-induced mouse ear inflammation. Int. Arch. Allergy Immunol. 111 (1996) 284-290
30. Refolo L.M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G.S., Sambamurti K., Duff K., and Pappolla M.A. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7 (2000) 321-331
31. Salem Jr. N., Moriguchi T., Greiner R.S., McBride K., Ahmad A., Catalan J.N., and Slotnick B. Alterations in brain function after loss of docosahexaenoate due to dietary restriction of n-3 fatty acids. J. Mol. Neurosci. 16 (2001) 299-307
32. Schley P.D., Jijon H.B., Robinson L.E., and Field C.J. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 92 (2005) 187-195
33. Simard A.R., Soulet D., Gowing G., Julien J.P., and Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 (2006) 489-502
34. Simopoulos A.P. n-3 fatty acids and human health: defining strategies for public policy. Lipids 36 (2001) S83-S89
35. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta 1486 (2000) 219-231
36. Strokin M., Sergeeva M., and Reiser G. Role of Ca2+-independent phospholipase A2 and n-3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation. Int. J. Dev. Neurosci. 22 (2004) 551-557
37. Szoka Jr. F., and Papahadjopoulos D. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu. Rev. Biophys. Bioeng. 9 (1980) 467-508
38. Williard D.E., Harmon S.D., Kaduce T.L., Preuss M., Moore S.A., Robbins M.E., and Spector A.A. Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. J. Lipid Res. 42 (2001) 1368-1376
39. Yehuda S., Rabinovitz S., and Mostofsky D.I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J. Neurosci. Res. 56 (1999) 565-570